Quick access for journalists to the latest corporate information.
We continue to drive our sustainability strategy forward.
12/05/2023
Vetter’s European clinical site receives permanent Manufacturer’s Authorization
11/09/2023
Ongoing investments in the supply chain for complex injectable medications
10/17/2023
PDF | 9 MB
Download
Do you have any questions, do you need more insights, or would you like to be included in our press distribution list? We would be pleased to assist you.
Corporate Spokesperson / Media Relations +49 751 3700 - 3729 (Germany) Vetter Pharma International GmbH Eywiesenstrasse 5 88212 Ravensburg Contact form
